Kidney allograft fibrosis and atrophy early after living donor transplantation

American Journal of Transplantation

Volumn 5, Issue 5, 2005, Pages 1130-1136

  Cosio, Fernando G ^a   Grande, Joseph P ^a   Larson, Timothy S ^a   Gloor, James M ^a   Velosa, Jorge A ^a   Textor, Stephen C ^a   Griffin, Matthew D ^a   Stegall, Mark D ^a  

^a MAYO CLINIC   (United States)

Author keywords

Chronic allograft nephropathy; Kidney transplant; Living donors; Protocol biopsies

Indexed keywords

IOTALAMIC ACID;

ADULT; AGED; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DECEASED DONOR; FEMALE; GLOMERULUS FILTRATION RATE; GRAFT SURVIVAL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INCIDENCE; KIDNEY ALLOGRAFT; KIDNEY ATROPHY; KIDNEY BIOPSY; KIDNEY DONOR; KIDNEY FIBROSIS; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY TUBULE; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RISK FACTOR;

ADULT; AGED; ATROPHY; BIOPSY; BODY MASS INDEX; CADAVER; FEMALE; FIBROSIS; GLOMERULAR FILTRATION RATE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; KIDNEY; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; RISK; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 17644375856     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2005.00811.x     Document Type: Article

References (24)

1. Hariharan S, Johnson CP, Breshnahan BA, Tarante SE, McIntosh MJ, Stablein D. Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med 2000; 342: 605-612.
2. Meier-Kriesche HU, Schold JD, Srinivas TR, Kaplan B. Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. Am J Transplant 2004; 4: 378-383.
3. Matas AJ, Humar A, Gillingham KJ et al. Five preventable causes of kidney graft loss in the 1990s: a single-center analysis. Kidney Int 2002; 62: 704-714.
4. Solez K, Axelsen RA, Benediktsson H et al. International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology. Kidney Int 1993; 44: 411-422.
5. Isoniemi H, Taskinen E, Hayry P. Histological chronic allograft damage index accurately predicts chronic renal allograft rejection. Transplantation 1994; 58: 1195-1198.
6. Rush DN, Jeffery JR, Gough J. Sequential protocol biopsies in renal transplant patients. Transplantation 1995; 59; 511-514.
7. Nicholson ML, McCulloch TA, Harper SJ et al. Early measurement of interstitial fibrosis predicts long-term renal function and graft survival in renal transplantation. Br J Surg 1996; 1082-1085.
8. Seron D, Moreso F, Bover J et al. Early protocol renal allograft biopsies and graft outcome. Kidney Int 1997; 310-316.
9. Solez K, Vincenti F, Filo RS. Histopathologic findings from 2-year protocol biopsies from a U.S. multicenter kidney transplant trial comparing tacrolimus versus cyclosporine. Transplantation 1998; 66: 1736-1740.
10. Nickerson P, Jeffery J, Gough J et al. Identification of clinical and histopathologic risk factors for diminished renal function 2 years posttransplant. J Am Soc Nephrol 1998; 9: 482-487.
11. Kuypers DRJ, Chapman JR, O'Connell PJ, Allen RDM, Nankivell BJ. Predictors of renal transplant histology at three months. Transplantation 1999; 67: 1222-1230.
12. Nankivell BJ, Borrows RJ, Fung CL, O'Connell PJ, Allen RD, Chapman JR. The natural history of chronic allograft nephropathy. N Engl J Med 2003; 349: 2326-2333.
13. Gloor JM, DeGoey SR, Pineda AA et al. Overcoming a positive crossmatch in living-donor kidney transplantation. Am J Transplant 2003; 3: 1017-1023.
14. Wilson DM, Bergert JH, Larson TS, Liedtke RR. GFR determined by nonradiolabeled iothalamate using capillary electrophoresis. Am J Kidney Dis 1997; 30: 646-652.
15. Levey AS, Greene T, Schluchter MD et al. Glomerular filtration rate measurements in clinical trials. Modification of Diet in Renal Disease Study Group and the Diabetes Control and Complications Trial Research Group. J Am Soc Nephrol 1993; 4: 1159-1171.
16. Racusen LC, Solez K, Colvin RB et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999; 55: 713-723.
17. Nickeleit V, Hirsch HH, Binet IF et al. Polyomavirus infection of renal allograft recipients: from latent infection to manifest disease. J Am Soc Nephrol 1999; 10: 1080-1089.
18. Buehrig CK, Lager DJ, Stegall M et al. The influence of surveillance renal allograft biopsy on diagnosis and prognosis of Polyomavirus-associated nephropathy. Kidney Int 2003; 64: 665-673.
19. Flechner SM, Kurian SM, Solez K et al. De novo kidney transplantation without use of calcineurin inhibitors preserves renal structure and function at two years. Am J Transplant 2004; 4: 1776-1785.
20. Sijpkens YW, Joosten SA, Wong MC et al. Immunologic risk factors and glomerular C4d deposits in chronic transplant glomerulopathy. Kidney Int 2004; 65: 2409-2418.
21. Furness PN, Taub N. International variation in the interpretation of renal transplant biopsies: Report of the CERTPAP Project. Kidney Int 2001; 60: 1998-2012.
22. Grimm PC, Nickerson P, Gough J et al. Computerized image analysis of Sirius Red-stained renal allograft biopsies as a surrogate marker to predict long-term allograft function. J Am Soc Nephrol 2003; 14: 1662-1668.
23. Diaz Encarnacion MM, Griffin MD, Slezak JM et al. Correlation of quantitative digital image analysis with the glomerular filtration rate in chronic allograft nephropathy. Am J Transplant 2004; 4: 248-256.
24. Shishido S, Asanuma H, Nakai H et al. The impact of repeated subclinical acute rejection on the progression of chronic allograft nephropathy. J Am Soc Nephrol 2003; 14: 1046-1052.